Biomedical Innovation Around the World

Biomedical Innovation Around the World


The Duke-Margolis has engaged with multiple stakeholders to advance work on biomedical innovation and provide guidance on best practices to address regulatory challenges. 


See specific projects below



product development

Mapping Global Health Research & Development

This study aimed to identify how the US government funding decisions are determined and explore how the US government could improve its support for global health research and product development. 

Funder: Global Health Technologies Coalition

Duke Lead: Duke's Center for Policy Impact in Global Health



Transferable Exclusivity Voucher

Duke-Margolis is examining whether a transferable exclusivity voucher (TEV) program for neglected tropical diseases is desirable and feasible, and if so, how to implement it. The research team conducted a stakeholder analysis, including over 20 interviews and a roundtable, and literature review. 

Funder: Gates Foundation

Duke Lead: Margolis

med prod

Medical product regulatory reform in China

The Center has engaged with the National Medical Product Administration to help bring clinical trials and evidentiary standards in-line with international best practices. 


Duke-Margolis Team

Jonathan Gonzalez-Smith

Jonathan Gonzalez-Smith, MPAff

Assistant Research Director

Andrea Thoumi headshot

Andrea Thoumi, MPP, MSc

Area Lead, Community Health and Equity
Faculty Director of Health Equity Educational Programming
Senior Team Member
Anti-Racism and Equity Committee Member
Core Faculty Member
Adjunct Assistant Professor
2020 Intern Mentor

Gavin Yamey

Gavin Yamey, MD, MPH

Hymowitz Professor of the Practice of Global Health, Duke Global Health Institute
Margolis Core Faculty
2020 Intern Mentor

Morgan Romine headshot

Morgan Romine, MPA

Chief of Staff
Senior Team Member

Beth Boyer headshot

Beth Boyer, MPH

Policy Research Associate